Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THNSL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | DYNLRB1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | ANP32B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | GJA5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | RPL10A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | UBTF | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | GPHN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | SHARPIN | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | SYNC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | PRPF4B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |